Recent Updates
Recently added Catalysts
ORGO Positive Sentiment Score: 70/100

Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2025 Financial Results on August 7, 2025

Tuesday, July 22, 2025 1 min read
Key Takeaway: Organogenesis Holdings Inc. will report its second quarter financial results for fiscal year 2025 on August 7, 2025. The report will be released after market close, followed by a conference call at 5:00 p.m. ET. The call will include a discussion of the results and a Q&A session.

Market Sentiment Analysis

POSITIVE FACTORS

  • Organogenesis is a leading company in regenerative medicine.
  • The upcoming financial results may indicate growth and success.
  • Management will provide a corporate update during the call.

Full Press Release Details

CANTON, Mass., July 22, 2025 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical and Sports Medicine markets, today announced that second quarter of fiscal year 2025 financial results will be reported after the market closes on Thursday, August 7th.
Management will host a conference call at 5:00 p.m. Eastern Time on August 7th to discuss the results of the quarter, and to provide a corporate update with a question and answer session. Those who would like to participate may access the live webcasthere, or access the teleconference by dialing 800-715-9871 (646-307-1963 for international callers) and providing access code: 634899. The live webcast can also be accessed via the company’s website atinvestors.organogenesis.com. The webcast will be archived on the company website for approximately one year.
About Organogenesis Holdings Inc.Organogenesis Holdings Inc. is a leading regenerative medicine company focused on the development, manufacture, and commercialization of solutions for the advanced wound care and surgical and sports medicine markets. Organogenesis offers a comprehensive portfolio of innovative regenerative products to address patient needs across the continuum of care. For more information, visitwww.organogenesis.com.

Frequently Asked Questions

When will Organogenesis report its Q2 FY2025 results?

Organogenesis will report its Q2 FY2025 financial results on August 7, 2025.

What time is the conference call for Q2 FY2025 results?

The conference call will take place at 5:00 p.m. Eastern Time on August 7, 2025.

How can I access the conference call?

You can access the call by dialing 800-715-9871 or via the live webcast on their website.

Will the conference call include a Q&A session?

Yes, the conference call will include a question and answer session.

Tags: ORGO Viatris Investor Conferences Healthcare Organogenesis financial results regenerative medicine conference call
Last updated: Jul 22, 2025